COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Amager Project: Intervention After Suicide Attempt (Amager)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00821756
Recruitment Status : Unknown
Verified January 2009 by Rigshospitalet, Denmark.
Recruitment status was:  Active, not recruiting
First Posted : January 13, 2009
Last Update Posted : January 13, 2009
Sponsor:
Collaborator:
Ministry of Social Affairs, Denmark
Information provided by:
Rigshospitalet, Denmark

Brief Summary:

Background:

Repetition rate after a suicide attempt and self harm is very high, about 12-30 percent. Studies, reviewed by Hawton, 1999 show a lack of evidence for psychosocial interventions. Compliance with aftercare is also often very poor.

Objective:

Inspired by the Norwegian Baerum project, the aim is to study if active, assertive outreach, seeking contact, talking about problem solution, motivate to comply to other appointments, will reduce repetition of suicidal acts in the following years.

Methods:

The design is a prospective randomized, controlled trial. The patients (immediately after a suicide attempt or deliberate self harm)) included are randomized to intervention or standard (treatment as usual), aiming at at least 60 persons in each arm. The intervention is carried out through research nurses with about 8 home visits, phone contact, phone messaging, e-mails.Included are persons 12 years of age and older, danish speaking without translator and without diagnoses of severe mental illness (schizophrenia, bipolar illness, mania and severe/psychotic depression) or severe dementia.

Results:

Outcome is measured by repetition of suicidal act (suicide attempt, self harm or completed suicide)as recorded in medical records and by the Danish Cause of Death Register. Repetition measured by persons and by acts throughout 1 year, 2 and 3 years periods. Additional outcome is number and character of health system contacts.


Condition or disease Intervention/treatment Phase
Suicidal Behaviour Repetition of Suicidal Behaviour Behavioral: OPAC (Outreach, Problem solving, Adherence, Continuity) Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 133 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Prevention
Official Title: The Amager Project. Intervention After Suicide Attempt: A Randomized Study.
Study Start Date : January 2005
Actual Primary Completion Date : August 2008
Estimated Study Completion Date : August 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Suicide

Arm Intervention/treatment
Experimental: 1
Assertive intervention in OPAC-style: Outreach,problem solving,adherence,continuity
Behavioral: OPAC (Outreach, Problem solving, Adherence, Continuity)
Assertive outreach immediately after the suicide attempt with about 8 home visits plus contact by telephone, phone messages, e-mails. Duration of intervention 6 months.

No Intervention: 2
Control arm: Treatment as usual



Primary Outcome Measures :
  1. Persons repeating a suicidal act [ Time Frame: One, two and three years ]

Secondary Outcome Measures :
  1. Acts of suicidal behaviour Contacts with health system [ Time Frame: One, two and three years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   12 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Suicide attempt and self harm

Exclusion Criteria:

  • Severe mental diagnosis (schizophrenia, psychosis, bipolar affective disorder, severe/psychotic depression, severe dementia)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00821756


Locations
Layout table for location information
Denmark
Psychiatric Centre Amager, Copenhagen University Hospital
Copenhagen S, Denmark, DK-2300
Sponsors and Collaborators
Rigshospitalet, Denmark
Ministry of Social Affairs, Denmark
Investigators
Layout table for investigator information
Principal Investigator: August G. Wang, M.D. Psychiatric Centre Amager, Copenhagen University Hospital
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: August G. Wang, Psychiatric Centre Amager, Copenhagen, Denmark
ClinicalTrials.gov Identifier: NCT00821756    
Other Study ID Numbers: AH-2005
First Posted: January 13, 2009    Key Record Dates
Last Update Posted: January 13, 2009
Last Verified: January 2009
Keywords provided by Rigshospitalet, Denmark:
Suicidal behaviour
Attempted suicide
Self harm
Suicide
Health system contacts
Contacts with health system
Additional relevant MeSH terms:
Layout table for MeSH terms
Suicide
Suicide, Attempted
Self-Injurious Behavior
Behavioral Symptoms